InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 170659

Saturday, 04/01/2017 1:36:47 PM

Saturday, April 01, 2017 1:36:47 PM

Post# of 345950

Plaintiff:

Kenneth Blumberg -vs-


Defendants:

Howard H. Pien, Chair BOD Pres/CEO since 2007
Patricia M. Danzon, Director since 2005
Robert C. Dinerstein, Director since 2005
Marc Rubin, Director since 2007
Ronald J. Saldarini, Director since 2001
Charles R. Schaller, Director since 1987 (Chair BOD 87-97)
Julius A. Vida, Director since 1994

http://jimedwardsnrx.files.wordpress.com/2009/07/medarex-complaint.pdf



I wonder which BP will make a run for Peregrine Pharmaceuticals and I just find it interesting Howard Pien makes the rounds again.... way back accepting breadcrumb money from BMY when he sat on the BOD of Medarex....so now he sits on with JUNO and I will take SK any day of the week as a BOD to protect ones IP tech ...vs Howard Pien which was part of that BMY buyout...and remember, Medarex had collaborations with Peregrine...(so who knows what seeds were planted way back that led to Fargo sabotage...especially since BMY was involved in Medarex and hmmmm.... makes one ask many questions)
http://ir.peregrineinc.com/releasedetail.cfm?ReleaseID=266115

The puzzle of all puzzles unfolding and Peregrine, remember....you have PS Targeting that all will require to stay in business and don't forget those that made things difficult in the past while in any negotiations. : )
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News